- Home
- Infections and Infectious Diseases
- Long-Acting Capsid Inhibition: Clinical Outcomes of Lenacapavir in Multidrug-Resistant HIV-1
6mo3 min read
Medical Article
Introduction For most patients with HIV-1 infection, effective antiretroviral therapy achieves durable viral suppression. However, a subset of patients experiences multiple treatment failures due to viral resistance or intolerable side effects, leaving them without reliable options and at increased risk of hospitalization, progression to AIDS, and

Long-Acting Capsid Inhibition: Clinical Outcomes of Lenacapavir in Multidrug-Resistant HIV-1
206 Reached
Similar Content

Woman presented with Fever of Unknown Origin
7739 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes

Use of Clindamycin for Managing Bacterial Vaginosis
11253 Reached29 Comments8 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
859 Reached9 Comments11 Likes

Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes
